VeraBIND™ Tau is a new noninvasive test that offers 96 percent sensitivity and 90 percent specificity, empowering earlier and more accessible Alzheimer's detection
Study suggests the number of US adults who will probably develop dementia each year will increase from around 514,000 in 2020 to approximately 1 million in 2060
University of Texas Health Science Center at Houston
By linking epilepsy to specific genetic mutations, the research offers a new framework for understanding the disorder and developing therapies that address its root causes
Scientists report that damage starts much earlier than the death of dopamine neurons
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.